Bitsphi — Seed (estimated) · €2.85M

This was Bitsphi Diagnosis's first round, led by Bullnet Capital from its Bullnet Capital III fund. The InnovFin SME Guarantee (Horizon 2020) backed it, and it was meant to fund the first commercial version of the ADHD diagnosis platform and its clinical trials. In February 2022, CDTI said its Innvierte programme had joined alongside Bullnet, committing €1.35M of a €2.85M round.